Skip to main content

Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) is a Western equine encephalitis virus Full Length protein, expressed in HEK 293T, with >80% purity and suitable for SDS-PAGE, ELISA, WB.

Be the first to review this product! Submit a review

Images

Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726), expandable thumbnail
  • SDS-PAGE - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726), expandable thumbnail
  • ELISA - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (AB233726), expandable thumbnail

Key facts

Purity
>80% SDS-PAGE
Expression system
HEK 293T cells
Tags
His tag C-Terminus
Applications
SDS-PAGE, ELISA, WB
Biologically active
No

Reactivity data

Application
SDS-PAGE
Reactivity
Reacts
Dilution info
-
Notes

-

Application
ELISA
Reactivity
Reacts
Dilution info
-
Notes

-

Application
WB
Reactivity
Reacts
Dilution info
-
Notes

-

Associated Products

Select an associated product type

1 product for Alternative Product

Target data

Function

Capsid protein. Forms an icosahedral capsid with a T=4 symmetry composed of 240 copies of the capsid protein surrounded by a lipid membrane through which penetrate 80 spikes composed of trimers of E1-E2 heterodimers (By similarity). The capsid protein binds to the viral RNA genome at a site adjacent to a ribosome binding site for viral genome translation following genome release (By similarity). Possesses a protease activity that results in its autocatalytic cleavage from the nascent structural protein (By similarity). Following its self-cleavage, the capsid protein transiently associates with ribosomes, and within several minutes the protein binds to viral RNA and rapidly assembles into icosahedric core particles (By similarity). The resulting nucleocapsid eventually associates with the cytoplasmic domain of the spike glycoprotein E2 at the cell membrane, leading to budding and formation of mature virions (By similarity). In case of infection, new virions attach to target cells and after clathrin-mediated endocytosis their membrane fuses with the host endosomal membrane (By similarity). This leads to the release of the nucleocapsid into the cytoplasm, followed by an uncoating event necessary for the genomic RNA to become accessible (By similarity). The uncoating might be triggered by the interaction of capsid proteins with ribosomes (By similarity). Binding of ribosomes would release the genomic RNA since the same region is genomic RNA-binding and ribosome-binding (By similarity). Specifically inhibits interleukin-1 receptor-associated kinase 1/IRAK1-dependent signaling during viral entry, representing a means by which the alphaviruses may evade innate immune detection and activation prior to viral gene expression (By similarity). Inhibits host transcription (By similarity). Forms a tetrameric complex with XPO1/CRM1 and the nuclear import receptor importin (By similarity). This complex blocks the central channel of host nuclear pores thereby inhibiting the receptor-mediated nuclear transport and thus the host mRNA and rRNA transcription (By similarity). The inhibition of transcription is linked to a cytopathic effect on the host cell (By similarity). Assembly protein E3. Provides the signal sequence for the translocation of the precursor of protein E3/E2 to the host endoplasmic reticulum. Furin-cleaved E3 remains associated with spike glycoprotein E1 and mediates pH protection of the latter during the transport via the secretory pathway. After virion release from the host cell, the assembly protein E3 is gradually released in the extracellular space. Spike glycoprotein E2. Plays an essential role in viral attachment to target host cell, by binding to the cell receptor. Synthesized as a pE2 precursor which is processed by furin at the cell membrane just before virion budding, giving rise to E2-E1 heterodimer. The pE2-E1 heterodimer is stable, whereas E2-E1 is unstable and dissociate at low pH. pE2 is processed at the last step, presumably to avoid E1 fusion activation before its final export to cell surface. E2 C-terminus contains a transitory transmembrane that would be disrupted by palmitoylation, resulting in reorientation of the C-terminal tail from lumenal to cytoplasmic side. This step is critical since E2 C-terminus is involved in budding by interacting with capsid proteins. This release of E2 C-terminus in cytoplasm occurs lately in protein export, and precludes premature assembly of particles at the endoplasmic reticulum membrane. Protein 6K: Acts as a viroporin that participates in virus glycoprotein processing, cell permeabilization and budding of viral particles. Disrupts the calcium homeostasis of the cell, probably at the endoplasmic reticulum level resulting in the increased levels of cytoplasmic calcium. Because of its lipophilic properties, the 6K protein is postulated to influence the selection of lipids that interact with the transmembrane domains of the glycoproteins, which, in turn, affects the deformability of the bilayer required for the extreme curvature that occurs as budding proceeds. Present in low amount in virions, about 3% compared to viral glycoproteins. Spike glycoprotein E1. Class II viral fusion protein. Fusion activity is inactive as long as E1 is bound to E2 in mature virion. After virus attachment to target cell and endocytosis, acidification of the endosome would induce dissociation of E1/E2 heterodimer and concomitant trimerization of the E1 subunits. This E1 trimer is fusion active, and promotes release of viral nucleocapsid in cytoplasm after endosome and viral membrane fusion. Efficient fusion requires the presence of cholesterol and sphingolipid in the target membrane.

Additional Targets

Western Equine Encephalitis Virus E3E2

Alternative names

Recommended products

Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) is a Western equine encephalitis virus Full Length protein, expressed in HEK 293T, with >80% purity and suitable for SDS-PAGE, ELISA, WB.

Key facts

Purity
>80% SDS-PAGE
Expression system
HEK 293T cells
Applications
SDS-PAGE, ELISA, WB
Accession
P13897-1
Animal free
No
Species
Western equine encephalitis virus
Concentration
Loading...
Storage buffer

Constituents: PBS, 10% Glycerol (glycerin, glycerine)

Sequence info

Amino acid sequence

Accession
P13897
Protein length
Full Length
Predicted molecular weight
54 kDa
Nature
Recombinant
Tags
His tag C-Terminus

Specifications

Form
Liquid
Additional notes

Purified by FPLC

General info

Function

Capsid protein

Post-translational modifications

Structural polyprotein: Specific enzymatic cleavages in vivo yield mature proteins. Capsid protein is auto-cleaved during polyprotein translation, unmasking a signal peptide at the N-terminus of the precursor of E3/E2. The remaining polyprotein is then targeted to the host endoplasmic reticulum, where host signal peptidase cleaves it into pE2, 6K and E1 proteins. pE2 is further processed to mature E3 and E2 by host furin in trans-Golgi vesicle.

Subcellular localisation
Host nucleus

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The Western Equine Encephalitis Virus E3E2 is a glycoprotein complex involved in viral entry and fusion. It is alternatively referred to as WEEV E3E2. This protein forms a heterodimer with an estimated molecular mass of approximately 50 kDa. It localizes on the viral membrane surface playing a critical role in mediating the interaction with host cell receptors. The E3E2 complex facilitates viral attachment and subsequent entry into host cells which is essential for the lifecycle of Western Equine Encephalitis Virus.

Biological function summary

The E3E2 complex initiates mechanisms important for infection. It operates as part of the viral envelope embedding within it to mediate fusion between the viral and cellular membranes. This facilitates the release of the viral genome into the host cytoplasm. The E3 segment acts as a regulatory peptide while E2 binds receptors on the host cell surface triggering fusion events. Once the virus enters the host cell it disrupts normal cellular processes to promote viral replication.

Pathways

The E3E2 glycoprotein complex interacts with host cellular processes involved in viral pathogenesis. It is intricately involved in membrane fusion pathways which are central to the viral entry process. The E3E2 complex interacts with host cell proteins such as clathrin and other components of receptor-mediated endocytosis pathways. These interactions facilitate efficient viral uptake and endosomal escape integrated into pathways important to its infectious cycle.

Associated diseases and disorders

The E3E2 complex has a direct link with Western Equine Encephalitis a mosquito-borne viral disease affecting both equines and humans. This disease can lead to encephalitis causing inflammation of the brain. The E3E2 proteins are involved in the pathogenicity of the virus with their functions critical in leading to disease symptoms. Additionally E3E2 is relevant to studying other encephalitic viruses as it shares functional similarities with proteins from related alphaviruses providing insights into broader viral pathology.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

3 product images

  • Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726), expandable thumbnail

    Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726)

    TMB substrate

    All lanes: Anti-Western Equine Encephalitus Virus E2 rabbit polyclonal at 0.25 µg/mL

    Lane 1: Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.05 µg

    Lane 2: Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.1 µg

    Lane 3: Western blot - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726) at 0.2 µg

    Secondary

    All lanes: Anti-rabbit IgG-HRP

  • SDS-PAGE - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726), expandable thumbnail

    SDS-PAGE - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726)

    SDS-PAGE analysis of ab233726 under denaturing and reducing conditions.

    Lane 1: 1 μg

    Lane 2: 5 μg

  • ELISA - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726), expandable thumbnail

    ELISA - Recombinant Western Equine Encephalitis Virus E3E2 protein (His tag) (ab233726)

    Plate was coated with ab233726 starting at 800 ng/well, serially diluted in DPBS. Washed plate was detected using Rabbit Anti-WEEV E2 pAb at 1 μg/mL. OD650 is reported.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com